Literature DB >> 17449900

Interventions to reduce weight gain in schizophrenia.

Guy Faulkner1, Tony Cohn, Gary Remington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17449900      PMCID： PMC2526141          DOI： 10.1093/schbul/sbm022

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  28 in total

1.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Authors:  Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

Review 2.  Management of antipsychotic-related weight gain.

Authors:  Lawrence Maayan; Christoph U Correll
Journal:  Expert Rev Neurother       Date:  2010-07       Impact factor: 4.618

3.  Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study.

Authors:  Jian-Ping Zhang; Jeffrey J Weiss; Melissa McCardle; Hope Klopchin; Eileen Rosendahl; Lawrence Maayan; Antonio Convit; John M Kane; Peter Manu; Christoph U Correll
Journal:  J Clin Psychopharmacol       Date:  2012-08       Impact factor: 3.153

Review 4.  Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.

Authors:  Lawrence Maayan; Julia Vakhrusheva; Christoph U Correll
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

Review 5.  Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.

Authors:  Samir Kumar Praharaj; Amlan Kusum Jana; Nishant Goyal; Vinod Kumar Sinha
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

6.  The appropriateness of routine medication treatment for schizophrenia.

Authors:  Alexander S Young; Noosha Niv; Amy N Cohen; Christopher Kessler; Kirk McNagny
Journal:  Schizophr Bull       Date:  2008-11-07       Impact factor: 9.306

7.  Interventions for the metabolic syndrome in schizophrenia: a review.

Authors:  Evangelos Papanastasiou
Journal:  Ther Adv Endocrinol Metab       Date:  2012-10       Impact factor: 3.565

8.  Metabolic syndrome in people with schizophrenia: a review.

Authors:  Marc DE Hert; Vincent Schreurs; Davy Vancampfort; Ruud VAN Winkel
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

Review 9.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

Review 10.  Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?

Authors:  Hiram Joseph Wildgust; Mike Beary
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.